Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide plus Jintiange vs Teriparatide plus Calcium in Low-Turnover Severe Osteoporosis
ChiCTR2600130017Phase 4Not yet recruiting
- Sponsor
- Nanchuan District People's Hospital
- Start
- Aug 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in osteoporosis comparing Teriparatide + Jintiange capsule with Teriparatide + calcium carbonate (2 arms). Primary endpoint: Lumbar spine (L1–L4) bone mineral density (BMD). Planned start Aug 2026; status: not yet recruiting.
02
Drugs
teriparatidejintiangecalcium carbonate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR2600130017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130017.